Acer Therapeutics Inc (NASDAQ:ACER)

18.94
Delayed Data
As of Apr 19
 -0.12 / -0.63%
Today’s Change
5.70
Today|||52-Week Range
22.63
+36.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.000.002.7K1.3K
 
 
 
 
Operating ExpensesGross Income0.000.00-2.7K-1.3K
 
 
 
General Expenses925.9K677.9K3.4M4.2M
 
 
 
 
 
Research And Development206.0K-796.002.1M1.8M
 
 
 
 
 
Total Operating Expenses925.9K677.9K3.4M4.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-925.9K-677.9K-3.4M-4.2M
 
 
 
 
 
Interest Expense On Debt1.2K614.00120.2K2.1K
 
 
 
 
 
Other Expenses470.00-30.00-970.00-15.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-926.3K-678.2K-3.5M-4.2M
 
 
 
 
 
Net Income-926.3K-678.2K-3.5M-4.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS733.7K739.4K3.2M6.6M
 
 
 
 
 
Shares To Calculate EPS Diluted733.7K739.4K3.2M6.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.24-$0.93-$1.09-$0.63
 
 
 
 
 
EPS Diluted-$1.24-$0.93-$1.09-$0.63